Literature DB >> 19857610

Postcholecystectomy syndrome (PCS).

S S Jaunoo1, S Mohandas, L M Almond.   

Abstract

The term postcholecystectomy syndrome (PCS) comprises a heterogeneous group of symptoms and findings in patients who have previously undergone cholecystectomy. Although rare, these patients may present with abdominal pain, jaundice or dyspeptic symptoms. Many of these complaints can be attributed to complications including bile duct injury, biliary leak, biliary fistula and retained bile duct stones. Late sequelae include recurrent bile duct stones and bile duct strictures. With the number of cholecystectomies being performed increasing in the laparoscopic era the number of patients presenting with PCS is also likely to increase. We briefly explore the syndrome and its main aetiological theories. Copyright 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19857610     DOI: 10.1016/j.ijsu.2009.10.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  36 in total

1.  Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.

Authors:  Juhyeun Kim; Andrew John Tabner; Graham David Johnson; Babette A Brumback; Abraham Hartzema
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

2.  Effects of Rowachol on prevention of postcholecystectomy pain after laparoscopic cholecystectomy: prospective multicenter randomized controlled trial.

Authors:  In Woong Han; O Choel Kwon; Min Gu Oh; Yoo Shin Choi; Seung Eun Lee
Journal:  HPB (Oxford)       Date:  2016-06-30       Impact factor: 3.647

3.  Adverse outcomes and short-term cost implications of bile duct injury during cholecystectomy.

Authors:  Stephen O'Brien; David Wei; Neal Bhutiani; Mohan K Rao; Stephen S Johnston; Anuprita Patkar; Gary C Vitale; Robert C G Martin
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

Review 4.  Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease.

Authors:  Yousef Al Talhi; Bader Hamza Shirah; Muteb Altowairqi; Yasmin Yousef
Journal:  Clin J Gastroenterol       Date:  2017-05-29

5.  Post-cholecystectomy syndrome: a retrospective study analysing the associated demographics, aetiology, and healthcare utilization.

Authors:  Saad Saleem; Simcha Weissman; Hector Gonzalez; Patricia Guzman Rojas; Faisal Inayat; Ali Alshati; Vinaya Gaduputi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

6.  Black bile of melancholy or gallstones of biliary colics: historical perspectives on cholelithiasis.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-08-08       Impact factor: 3.199

7.  Gallstones, cholecystectomy, and risk of digestive system cancers.

Authors:  Leticia Nogueira; Neal D Freedman; Eric A Engels; Joan L Warren; Felipe Castro; Jill Koshiol
Journal:  Am J Epidemiol       Date:  2014-01-26       Impact factor: 4.897

8.  Increased Risk of Depressive Disorder following Cholecystectomy for Gallstones.

Authors:  Ming-Chieh Tsai; Chao-Hung Chen; Hsin-Chien Lee; Herng-Ching Lin; Cha-Ze Lee
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

9.  The cerebral mechanism underlying the acupoints with specific effect for gallbladder stone disease: protocol for a randomized controlled task-fMRI trial.

Authors:  Ning Sun; Yuan-Fang Zhou; Jie Zhou; Wen-Wei Zuo; Xiang-Yin Ye; Xiao-Dong Deng; Zheng-Jie Li; Shi-Rui Cheng; Yu-Zhu Qu; Jun Zhou; Rui-Rui Sun; Fan-Rong Liang
Journal:  Trials       Date:  2021-06-14       Impact factor: 2.279

10.  Morpho-functional gastric pre-and post-operative changes in elderly patients undergoing laparoscopic cholecystectomy for gallstone related disease.

Authors:  Giovanni Aprea; Alfonso Canfora; Antonio Ferronetti; Antonio Giugliano; Francesco Guida; Antonio Braun; Melania Battaglini Ciciriello; Federica Tovecci; Giovanni Mastrobuoni; Fabrizio Cardin; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.